anova followed by appropriate post hoc analyses graphpad prizm v5.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
anova followed by appropriate post hoc analyses graphpad prizm v5.0
Anova Followed By Appropriate Post Hoc Analyses Graphpad Prizm V5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+followed+by+appropriate+post+hoc+analyses+graphpad+prizm+v5%2E0/anova+followed+by+appropriate+post+hoc+analyses+graphpad+prizm+v5+0/pm20931971-416-8-16
Average 90 stars, based on 1 article reviews
Anova Followed By Appropriate Post Hoc Analyses Graphpad Prizm V5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+followed+by+appropriate+post+hoc+analyses+graphpad+prizm+v5%2E0/anova+followed+by+appropriate+post+hoc+analyses+graphpad+prizm+v5+0/pm20931971-416-8-16
Average 90 stars, based on 1 article reviews
anova followed by appropriate post hoc analyses graphpad prizm v5.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models. Article Snippet: Joseph E. Payne, C eline Bonnefous, Kent T. Symons, Phan M. Nguyen, Marciano Sablad, Natasha Rozenkrants, Yan Zhang, Li Wang, ),z Nahid Yazdani,^,þ Andrew K. Shiau, Stewart A. Noble, Peter Rix, ),3 Tadimeti S. Rao, Christian A. Hassig, and Nicholas D. Smith* Department of Chemistry, Department of Biology, Department of Pharmacology, Department ofDrugMetabolism andPharmacokinetics, and Department of Analytical Chemistry , Kalypsys, Inc., 10420Wateridge Circle, San Diego, California 92121.. # These authors contributed equally to this work.. Current affiliation: Aragon Pharmaceuticals, San Diego, California 92121. |